"Designing Growth Strategies is in our DNA"

Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, Share & Industry Analysis, By Disease Indication (Arthritis, Migraine, Ophthalmic Diseases, and Others), By Route of Administration (Oral, and Parenteral), By Distribution Channel (Hospital Pharmacy Retail Pharmacy, and Online Pharmacy), and Regional Forecast, 2020-2032

Last Updated: February 03, 2025 | Format: PDF | Report ID: FBI102823

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
  4. Key Insights
    1. Prevalence of Major Diseases – For Key Countries
    2. Pipeline Analysis
    3. New Product Launches
    4. Key Industry Developments - Mergers, Acquisitions and Partnerships
    5. Key Trends
  5. Global Non-steroidal Anti-inflammatory Drugs (NSAIDs) Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Disease Indication
      1. Arthritis
      2. Migraine
      3. Ophthalmic Diseases
      4. Others
    3. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Parenteral
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Pharmacy
    5. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Non-steroidal Anti-inflammatory Drugs (NSAIDs) Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Disease Indication
      1. Arthritis
      2. Migraine
      3. Ophthalmic Diseases
      4. Others
    3. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Parenteral
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Pharmacy
    5. Market Analysis, Insights and Forecast – By Country
      1. U.S.
      2. Canada
  7. Europe Non-steroidal Anti-inflammatory Drugs (NSAIDs) Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Disease Indication
      1. Arthritis
      2. Migraine
      3. Ophthalmic Diseases
      4. Others
    3. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Parenteral
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Pharmacy
    5. Market Analysis, Insights and Forecast – By Countries/ Sub-region
      1. U.K.
      2. Germany
      3. France
      4. Spain
      5. Italy
      6. Scandinavia
      7. Rest of Europe
  8. Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAIDs) Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Disease Indication
      1. Arthritis
      2. Migraine
      3. Ophthalmic Diseases
      4. Others
    3. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Parenteral
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Pharmacy
    5. Market Analysis, Insights and Forecast – By Countries/ Sub-region
      1. Japan
      2. China
      3. India
      4. Australia
      5. Southeast Asia
      6. Rest of Asia Pacific
  9. Latin America Non-steroidal Anti-inflammatory Drugs (NSAIDs) Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Disease Indication
      1. Arthritis
      2. Migraine
      3. Ophthalmic Diseases
      4. Others
    3. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Parenteral
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Pharmacy
    5. Market Analysis, Insights and Forecast – By Countries/ Sub regions
      1. Brazil
      2. Mexico
      3. Rest of Latin America
  10. Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAIDs) Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Disease Indication
      1. Arthritis
      2. Migraine
      3. Ophthalmic Diseases
      4. Others
    3. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Parenteral
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Pharmacy
    5. Market Analysis, Insights and Forecast – By Countries/ Sub region
      1. South Africa
      2. GCC
      3. Rest of Middle East & Africa
  11. Competitive Analysis
    1. Key Industry Developments
    2. Global Market Share Analysis (2019)
    3. Company Profiles (Overview, Product  & Services, SWOT analysis, Recent developments, strategies, financials (based on availability))
      1. GlaxoSmithKline plc
        1. Overview,
        2. Product  & Services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      2. Pfizer Inc.
        1. Overview,
        2. Product  & Services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      3. Johnson & Johnson Services, Inc.
        1. Overview,
        2. Product  & Services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      4. Bayer AG
        1. Overview,
        2. Product  & Services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      5. AstraZeneca
        1. Overview,
        2. Product  & Services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      6. Boehringer Ingelheim International GmbH
        1. Overview,
        2. Product  & Services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      7. Zyla Life Sciences
        1. Overview,
        2. Product  & Services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      8. Horizon Therapeutics plc
        1. Overview,
        2. Product  & Services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      9. Other Prominent Players
        1. Overview,
        2. Product  & Services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
  12. Strategic Recommendations
Read Less

Figure 1:  Global Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Revenue Breakdown (US$ Bn, %) by Region, 2019 & 2027

Figure 2:  Global Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Value Share (%), by Disease Indication, 2019 & 2027

Figure 3:  Global Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast (US$ Bn), by Arthritis, 2016-2027

Figure 4:  Global Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast (US$ Bn), by Migraine, 2016-2027

Figure 5:  Global Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast (US$ Bn), by Ophthalmic Diseases, 2016-2027

Figure 6:  Global Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast (US$ Bn), by Others, 2016-2027

Figure 7:  Global Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Value Share (%), by Route of Administration, 2019 & 2027

Figure 8:  Global Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast (US$ Bn), by Oral, 2016-2027

Figure 9:  Global Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast (US$ Bn), by Parenteral, 2016-2027

Figure 10:  Global Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Value Share (%), by Distribution Channel, 2019 & 2027

Figure 11:  Global Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast (US$ Bn), by Hospital Pharmacy, 2016-2027

Figure 12:  Global Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast (US$ Bn), by Retail Pharmacy, 2016-2027

Figure 13:  Global Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast (US$ Bn), by Online Pharmacy, 2016-2027

Figure 14:  Global Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Value (US$ Bn), by Region, 2019 & 2027

Figure 15:  North America Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Value (US$ Bn), by Disease Indication, 2019 & 2027

Figure 16:  North America Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Value Share (%), by Disease Indication, 2019

Figure 17:  North America Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Value (US$ Bn), by Route of Administration, 2019 & 2027

Figure 18:  North America Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Value Share (%), by Route of Administration, 2019

Figure 19:  North America Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Value (US$ Bn), by Distribution Channel, 2019 & 2027

Figure 20:  North America Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Value Share (%), by Distribution Channel, 2019

Figure 21:  North America Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Value (US$ Bn), By Country, 2019 & 2027

Figure 22:  North America Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Value Share (%), By Country, 2019

Figure 23:  Europe Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Value (US$ Bn), by Disease Indication, 2019 & 2027

Figure 24:  Europe Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Value Share (%), by Disease Indication, 2019

Figure 25:  Europe Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Value (US$ Bn), by Route of Administration, 2019 & 2027

Figure 26:  Europe Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Value Share (%), by Route of Administration, 2019

Figure 27:  Europe Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Value (US$ Bn), by Distribution Channel, 2019 & 2027

Figure 28:  Europe Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Value Share (%), by Distribution Channel, 2019

Figure 29:  Europe Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Value (US$ Bn), By Country/ Sub-region, 2019 & 2027

Figure 30:  Europe Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Value Share (%), By Country/ Sub-region, 2019

Figure 31:  Asia Pacific Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Value (US$ Bn), by Disease Indication, 2019 & 2027

Figure 32:  Asia Pacific Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Value Share (%), by Disease Indication, 2019

Figure 33:  Asia Pacific Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Value (US$ Bn), by Route of Administration, 2019 & 2027

Figure 34:  Asia Pacific Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Value Share (%), by Route of Administration, 2019

Figure 35:  Asia Pacific Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Value (US$ Bn), by Distribution Channel, 2019 & 2027

Figure 36:  Asia Pacific Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Value Share (%), by Distribution Channel, 2019

Figure 37:  Asia Pacific Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Value (US$ Bn), By Country/ Sub-region, 2019 & 2027

Figure 38:  Asia Pacific Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Value Share (%), By Country/ Sub-region, 2019

Figure 39:  Latin America Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Value (US$ Bn), by Disease Indication, 2019 & 2027

Figure 40:  Latin America Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Value Share (%), by Disease Indication, 2019

Figure 41:  Latin America Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Value (US$ Bn), by Route of Administration, 2019 & 2027

Figure 42:  Latin America Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Value Share (%), by Route of Administration, 2019

Figure 43:  Latin America Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Value (US$ Bn), by Distribution Channel, 2019 & 2027

Figure 44:  Latin America Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Value Share (%), by Distribution Channel, 2019

Figure 45:  Latin America Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Value (US$ Bn), By Country/ Sub-region, 2019 & 2027

Figure 46:  Latin America Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Value Share (%), By Country/ Sub-region, 2019

Figure 47:  Middle East & Africa Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Value (US$ Bn), by Disease Indication, 2019 & 2027

Figure 48:  Middle East & Africa Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Value Share (%), by Disease Indication, 2019

Figure 49:  Middle East & Africa Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Value (US$ Bn), by Route of Administration, 2019 & 2027

Figure 50:  Middle East & Africa Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Value Share (%), by Route of Administration, 2019

Figure 51:  Middle East & Africa Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Value (US$ Bn), by Distribution Channel, 2019 & 2027

Figure 52:  Middle East & Africa Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Value Share (%), by Distribution Channel, 2019

Figure 53:  Middle East & Africa Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Value (US$ Bn), By Country/ Sub-region, 2019 & 2027

Figure 54:  Middle East & Africa Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Value Share (%), By Country/ Sub-region, 2019

Figure 55:  Global Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share (%), By Company, 2019

Table 1:  Global Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Revenue (US$ Bn) Forecast, by Disease Indication, 2016–2027

Table 2:  Global Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Revenue (US$ Bn) Forecast, by Route of Administration, 2016–2027

Table 3:  Global Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Revenue (US$ Bn) Forecast, by Distribution Channel, 2016–2027

Table 4:  Global Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Revenue (US$ Bn) Forecast, by Region, 2016-2027

Table 5:  North America Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Revenue (US$ Bn) Forecast, by Disease Indication, 2016-2027

Table 6:  North America Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Revenue (US$ Bn) Forecast, by Route of Administration, 2016-2027

Table 7:  North America Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Revenue (US$ Bn) Forecast, by Distribution Channel, 2016-2027

Table 8:  North America Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Revenue (US$ Bn) Forecast, By Country, 2016-2027

Table 9:  Europe Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Revenue (US$ Bn) Forecast, by Disease Indication, 2016-2027

Table 10:  Europe Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Revenue (US$ Bn) Forecast, by Route of Administration, 2016-2027

Table 11:  Europe Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Revenue (US$ Bn) Forecast, by Distribution Channel, 2016-2027

Table 12:  Europe Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Revenue (US$ Bn) Forecast, By Country/ Sub-region, 2016-2027

Table 13:  Asia Pacific Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Revenue (US$ Bn) Forecast, by Disease Indication, 2016-2027

Table 14:  Asia Pacific Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Revenue (US$ Bn) Forecast, by Route of Administration, 2016-2027

Table 15:  Asia Pacific Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Revenue (US$ Bn) Forecast, by Distribution Channel, 2016-2027

Table 16:  Asia Pacific Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Revenue (US$ Bn) Forecast, By Country/ Sub-region, 2016-2027

Table 17:  Latin America Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Revenue (US$ Bn) Forecast, by Disease Indication, 2016-2027

Table 18:  Latin America Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Revenue (US$ Bn) Forecast, by Route of Administration, 2016-2027

Table 19:  Latin America Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Revenue (US$ Bn) Forecast, by Distribution Channel, 2016-2027

Table 20:  Latin America Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Revenue (US$ Bn) Forecast, By Country/ Sub-region, 2016-2027

Table 21:  Middle East & Africa Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Revenue (US$ Bn) Forecast, by Disease Indication, 2016-2027

Table 22:  Middle East & Africa Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Revenue (US$ Bn) Forecast, by Route of Administration, 2016-2027

Table 23:  Middle East & Africa Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Revenue (US$ Bn) Forecast, by Distribution Channel, 2016-2027

Table 24:  Middle East & Africa Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Revenue (US$ Bn) Forecast, By Country/ Sub-region, 2016-2027

Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, Share and Global Industry Trend Forecast till 2032
  • REPORT UPDATE
    IN PROCESS
  • 2019-2032
    (In Process)
  • 2023
    (In Process)
Multi-report Purchase Plan
    A Customized Plan Will be Created Based on the number of reports you wish to purchase